CN1309554A - 生物活性组合物 - Google Patents

生物活性组合物 Download PDF

Info

Publication number
CN1309554A
CN1309554A CN99808549A CN99808549A CN1309554A CN 1309554 A CN1309554 A CN 1309554A CN 99808549 A CN99808549 A CN 99808549A CN 99808549 A CN99808549 A CN 99808549A CN 1309554 A CN1309554 A CN 1309554A
Authority
CN
China
Prior art keywords
composition
carrier
biologically active
active agent
chemical treatments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN99808549A
Other languages
English (en)
Chinese (zh)
Inventor
A·林达尔
H·哈格斯莱特
C·海曼
R·布赖兰德
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bioglan AB
Original Assignee
Bioglan AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioglan AB filed Critical Bioglan AB
Publication of CN1309554A publication Critical patent/CN1309554A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
CN99808549A 1998-05-14 1999-05-12 生物活性组合物 Pending CN1309554A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9801705-6 1998-05-14
SE9801705A SE9801705D0 (sv) 1998-05-14 1998-05-14 Biologically active composition

Publications (1)

Publication Number Publication Date
CN1309554A true CN1309554A (zh) 2001-08-22

Family

ID=20411319

Family Applications (1)

Application Number Title Priority Date Filing Date
CN99808549A Pending CN1309554A (zh) 1998-05-14 1999-05-12 生物活性组合物

Country Status (20)

Country Link
EP (1) EP1077677B1 (https=)
JP (1) JP2002514588A (https=)
KR (1) KR100766998B1 (https=)
CN (1) CN1309554A (https=)
AT (1) ATE252371T1 (https=)
AU (1) AU742921B2 (https=)
CA (1) CA2332110A1 (https=)
DE (2) DE69912271T2 (https=)
DK (1) DK1077677T3 (https=)
ES (1) ES2155049T3 (https=)
GR (1) GR20010300014T1 (https=)
HU (1) HUP0102002A3 (https=)
IL (2) IL139577A0 (https=)
NO (1) NO20005725L (https=)
NZ (1) NZ508074A (https=)
PL (1) PL344221A1 (https=)
SE (1) SE9801705D0 (https=)
TR (1) TR200003588T2 (https=)
WO (1) WO1999058109A1 (https=)
ZA (1) ZA200006476B (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003524652A (ja) * 2000-02-29 2003-08-19 ツァン，ツィエ 改良された経皮薬剤パッチ
WO2005013939A1 (en) 2003-08-06 2005-02-17 Nirmal Mulye Pharmaceutical composition containing water soluble drug
KR20090031726A (ko) 2006-06-14 2009-03-27 닥터 레디스 레보러터리즈 리미티드 국소용 조성물
WO2012028496A1 (de) * 2010-08-31 2012-03-08 Basf Se Verzweigte polyester auf basis von zitronensäure sowie deren herstellung und verwendung
KR20140089478A (ko) * 2011-01-13 2014-07-15 큐엘티 인코포레이티드 감광제의 국소 전달용 약학 조성물 및 그의 이용

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4940701A (en) * 1984-01-25 1990-07-10 Beecham Group P.L.C. Topical drug release system
SE9502244D0 (sv) * 1995-06-20 1995-06-20 Bioglan Ab A composition and a process for the preparation thereof
US5906830A (en) * 1995-09-08 1999-05-25 Cygnus, Inc. Supersaturated transdermal drug delivery systems, and methods for manufacturing the same
GB2306885B (en) * 1995-11-08 1999-07-14 Reckitt & Colmann Prod Ltd Supersaturated Pharmaceutical Compositions

Also Published As

Publication number Publication date
HUP0102002A3 (en) 2002-12-28
HUP0102002A2 (hu) 2002-03-28
ATE252371T1 (de) 2003-11-15
CA2332110A1 (en) 1999-11-18
DK1077677T3 (da) 2004-02-16
JP2002514588A (ja) 2002-05-21
TR200003588T2 (tr) 2001-06-21
IL139577A0 (en) 2002-02-10
SE9801705D0 (sv) 1998-05-14
EP1077677B1 (en) 2003-10-22
GR20010300014T1 (en) 2001-04-30
AU742921B2 (en) 2002-01-17
ZA200006476B (en) 2001-06-11
WO1999058109A1 (en) 1999-11-18
ES2155049T1 (es) 2001-05-01
KR100766998B1 (ko) 2007-10-15
AU4405199A (en) 1999-11-29
NZ508074A (en) 2003-01-31
DE69912271D1 (de) 2003-11-27
DE69912271T2 (de) 2004-08-26
NO20005725L (no) 2001-01-11
KR20010052349A (ko) 2001-06-25
ES2155049T3 (es) 2004-05-16
EP1077677A1 (en) 2001-02-28
DE1077677T1 (de) 2001-09-20
PL344221A1 (en) 2001-10-08
NO20005725D0 (no) 2000-11-13
IL139577A (en) 2007-07-04

Similar Documents

Publication Publication Date Title
CN1249679A (zh) 透皮治疗体系
CN1407898A (zh) 具有全身效应的新型局部雌激素孕激素组合物
EP3962456A1 (en) Production of nanoparticles and microparticles
JPH0250882B2 (https=)
CN1248165A (zh) 供局部应用的尼美舒利凝胶体系
CN1215838C (zh) 双氯芬酸钠贴剂及其制备方法
CN1309554A (zh) 生物活性组合物
CN1309553A (zh) 生物活性组合物
CN114921105B (zh) 一种电响应型丝素蛋白材料及其制备方法和电响应型丝素蛋白微针
MXPA00011077A (en) Biologically active composition
CN1750831A (zh) 痔疮治疗剂
CN110974962A (zh) 肿瘤免疫凝胶制剂的合成方法
JPH02124824A (ja) アゼラスチン或いはその塩類含有経皮適用製剤
CN1215880C (zh) 一种外用透皮贴剂的水溶性基质及其制备方法
CN1615838A (zh) 含二咖啡酰奎尼酸的组合物及其制备方法
JPH09110702A (ja) 海洋深層水含有ゲル製剤
CZ20004128A3 (cs) Biologicky aktivní prostředek a způsob jeho přípravy
CN121622622A (zh) 一种提高雌二醇生物利用度的透皮贴剂及其制备方法
JP3497308B2 (ja) 貼付剤
JP2004196748A (ja) キトサン含有消炎鎮痛皮膚外用液剤
CN1760223A (zh) 一种黏膜黏附性纳米粒及其制备方法和应用
MXPA00011082A (en) Biologically active composition
CN1814296A (zh) 一种巴布剂的基质及其制备方法
JP2005008585A (ja) 親水性粘着剤組成物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication